Apollo Hospitals Enterprise Ltd (AHEL) has announced a strategic corporate reorganization aimed at unlocking shareholder value through the separation and eventual listing of its omnichannel pharmacy and digital health businesses. The plan involves a demerger of these operations into a new entity (NewCo), which will later amalgamate with Apollo HealthCo Ltd (AHL) and pharmaceutical distributor Keimed Pvt Ltd. The new Indian-owned and controlled entity aims to become a market leader in digital healthcare and pharmacy distribution, with a revenue target of Rs. 25,000 crore by FY27.